Search results
5 questions facing pharma in 2024
BioPharma Dive via Yahoo Finance· 5 months agoNew drugs for obesity and cancer are the focus of many pharma companies, some of which are also grappling with how to manufacture complex cell and gene...
5 questions facing emerging biotech in 2024
BioPharma Dive via Yahoo Finance· 5 months agoAn unusual FTC challenge could have implications for startups, while industry watchers gauge whether the sector’s recent momentum will end a lengthy...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 1 month agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...